The UK’s NHS Business Services Authority's annual 'Prescribing for Diabetes - England 2015/16 to 2024/25' report reveals that diabetes treatments now account for 15% of all NHS prescription spending, ...

Danish allergy immunotherapy specialist ALK Abello today posted financial results which pleased investors, with its shares rising 6.2% to 199.50 kroner.

For what is reportedly the first time in decades, the American Academy of Pediatrics (AAP) has contradicted the US Centers for Disease Control and Prevention (CDC) over its recommended immunization ...